Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8725366 | Clinical Gastroenterology and Hepatology | 2017 | 28 Pages |
Abstract
In a study of the United States population, we found that the use of biologic agents to treat CD reduced the proportion of patients undergoing resection, but not among patients with SBS-IF. These findings indicate that biologic agents reduce some but not all features of CD. Studies are needed to identify patients at risk for SBS-IF, prevent and treat this complication, and identify new treatments.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Berkeley N. Limketkai, Alyssa M. Parian, Po-Hung Chen, Jean-Fréderic Colombel,